Appointment of Dr. Christopher von Jako as new CEO
21 juin 2023 09h00 HE
|
Polarean Imaging plc
Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company’s Board of Directors has appointed Christopher von Jako,...
First clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical Center
11 mai 2023 10h05 HE
|
Polarean Imaging plc
Durham, N.C. , May 11, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM:POLX), the medical imaging company, announces that the first clinical scan utilising its XENOVIEW (xenon Xe 129...
Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit
03 mai 2023 12h34 HE
|
Polarean Imaging plc
Durham, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging technology company, has been selected as one of the featured companies as a poster presenter at...
FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation
28 déc. 2022 08h00 HE
|
Polarean Imaging plc
Durham, N.C., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging technology company, announces that the U.S. Food and Drug Administration (“FDA”) has granted...